Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 15/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.51 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.47 |
| ▸ | F10 | P00742 | 1/20 | 0.46 |
| ▸ | CCR5 | P51681 | 1/20 | 0.46 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.45 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.45 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.44 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL5177249 | 0.99 | CCR2 (0.56) | CCR2OPRM1PTGDR2F10CCR5 | |
| Hydrochloric Acid SCHEMBL2906125 | 0.99 | CCR2 (0.56) | CCR2OPRM1PTGDR2F10CCR5 | |
| Hydrochloric Acid SCHEMBL313195 | 0.89 | CCR2 (0.65) | CCR2CCR5CXCR5CXCR3 | |
| Iodide SCHEMBL17555114 | 0.89 | CCR2 (0.65) | CCR2CCR5CXCR5CXCR3 | |
| SCHEMBL313427 | 0.78 | NPC1 (0.58) | CCR2 | |
| SCHEMBL13148385 | 0.78 | MAPK1 (0.63) | CCR2F10 | |
| Hydrochloric Acid SCHEMBL2906263 | 0.78 | CCR2 (0.57) | CCR2 | |
| Iodide SCHEMBL5178896 | 0.78 | CCR2 (0.57) | CCR2 | |
| Hydrochloric Acid SCHEMBL2907990 | 0.77 | MAPK1 (0.62) | CCR2F10 | |
| Iodide SCHEMBL17555183 | 0.77 | MAPK1 (0.62) | CCR2F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7799824-B2 | Quaternary salt CCR2 antagonists | ORAPHARMA, INC. (US) | 2010-09-21 | — | — | US | disclosed |